Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Rimexolone | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Rimexolone | hsa00030 | Pentose phosphate pathway | 5.64E-03 | 3 | P60891, P11413, P37837 | PRPS1, G6PD, TALDO1 | More | | Rimexolone | hsa00040 | Pentose and glucuronate interconversions | 9.59E-03 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Rimexolone | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Rimexolone | hsa00190 | Oxidative phosphorylation | 4.36E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Rimexolone | hsa00220 | Arginine biosynthesis | 4.88E-02 | 1 | P49448 | GLUD2 | More | | Rimexolone | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | | Rimexolone | hsa00471 | D-Glutamine and D-glutamate metabolism | 1.65E-02 | 1 | P49448 | GLUD2 | More | | Rimexolone | hsa00480 | Glutathione metabolism | 2.60E-05 | 5 | Q9UJ14, P11413, Q16772, P09211, P30041 | GGTL3, G6PD, GSTA3, GSTP1, PRDX6 | More | | Rimexolone | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Rimexolone | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Rimexolone | hsa00561 | Glycerolipid metabolism | 7.94E-03 | 3 | P15121, P14550, Q86XP1 | AKR1B1, AKR1A1, DGKH | More | | Rimexolone | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Rimexolone | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Rimexolone | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.74E-05 | 2 | P40925, P15104 | MDH1, GLUL | More | | Rimexolone | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Rimexolone | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Rimexolone | hsa00910 | Nitrogen metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | | Rimexolone | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Rimexolone | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-05 | 4 | Q16772, P78417, P09211, P11712 | GSTA3, GSTO1, GSTP1, CYP2C9 | More | | Rimexolone | hsa00982 | Drug metabolism - cytochrome P450 | 1.77E-04 | 4 | P11712, Q16772, P09211, P78417 | CYP2C9, GSTA3, GSTP1, GSTO1 | More | | Rimexolone | hsa00983 | Drug metabolism - other enzymes | 8.59E-04 | 4 | P32320, P05164, Q16772, P09211 | CDA, MPO, GSTA3, GSTP1 | More | | Rimexolone | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Rimexolone | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Rimexolone | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | | Rimexolone | hsa01230 | Biosynthesis of amino acids | 3.91E-02 | 3 | P51854, Q99707, P50213 | TKTL1, MTR, IDH3A | More | | Rimexolone | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Rimexolone | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Rimexolone | hsa03010 | Ribosome | 1.60E-02 | 9 | P30050, P40429, P62906, P62917, Q9H0U6, P36578, P05386, P62249, P23396 | RPL12, RPL13A, RPL10A, RPL8, MRPL18, RPL4, RPLP1, RPS16, RPS3 | More | | Rimexolone | hsa03013 | RNA transport | 8.19E-04 | 7 | Q15287, Q9UBU9, P35658, P63279, P55884, O15371, P20042 | RNPS1, NXF1, NUP214, UBE2I, EIF3B, EIF3D, EIF2S2 | More | | Rimexolone | hsa03030 | DNA replication | 1.48E-02 | 3 | P49005, P33993, P15927 | POLD2, MCM7, RPA2 | More | | Rimexolone | hsa03040 | Spliceosome | 5.45E-06 | 14 | Q14562, O43143, O60508, P08579, Q15427, P38159, P61978, Q07955, Q01130, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, SF3B4, RBMX, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Rimexolone | hsa03060 | Protein export | 6.41E-04 | 3 | Q15070, P37108, Q15005 | OXA1L, SRP14, SPCS2 | More | | Rimexolone | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Rimexolone | hsa04012 | ErbB signaling pathway | 1.66E-03 | 7 | P21860, P16333, Q13557, P19174, O14944, P42338, P01106 | ERBB3, NCK1, CAMK2D, PLCG1, EREG, PIK3CB, MYC | More | | Rimexolone | hsa04014 | Ras signaling pathway | 2.95E-05 | 10 | P42338, P20827, Q9NRA1, P49767, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PIK3CB, EFNA1, PDGFC, VEGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Rimexolone | hsa04015 | Rap1 signaling pathway | 4.83E-03 | 8 | P20827, Q9NRA1, P49767, P11215, Q13009, P42338, P0DP23, P19174 | EFNA1, PDGFC, VEGFC, ITGAM, TIAM1, PIK3CB, CALM1, PLCG1 | More | | Rimexolone | hsa04020 | Calcium signaling pathway | 2.71E-07 | 16 | P27987, Q96DU7, P21796, P45880, Q13557, P21860, P19174, P0DP23, P05141, P12236, P51828, P26678, P63092, P23634, Q9NRA1, P49767 | ITPKB, ITPKC, VDAC1, VDAC2, CAMK2D, ERBB3, PLCG1, CALM1, SLC25A5, SLC25A6, ADCY7, PLN, GNAS, ATP2B4, PDGFC, VEGFC | More | | Rimexolone | hsa04022 | cGMP-PKG signaling pathway | 1.26E-03 | 9 | P61586, P26678, Q99941, P18848, P23634, P51828, P05141, P12236, P45880 | RHOA, PLN, CREBL1, ATF4, ATP2B4, ADCY7, SLC25A5, SLC25A6, VDAC2 | More | | Rimexolone | hsa04024 | cAMP signaling pathway | 3.37E-02 | 3 | P63092, P26678, P61586 | GNAS, PLN, RHOA | More | | Rimexolone | hsa04062 | Chemokine signaling pathway | 3.26E-04 | 11 | P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q13009, P14598, P42224, P25963 | LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, TIAM1, NCF1, STAT1, NFKBIA | More | | Rimexolone | hsa04064 | NF-kappa B signaling pathway | 1.09E-04 | 11 | P10415, Q13489, O00463, Q13546, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341, Q9UNE0 | BCL2, BIRC3, TRAF5, RIPK1, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1, EDAR | More | | Rimexolone | hsa04070 | Phosphatidylinositol signaling system | 1.12E-02 | 5 | P19174, P0DP23, P42338, P23743, P27987 | PLCG1, CALM1, PIK3CB, DGKA, ITPKB | More | | Rimexolone | hsa04071 | Sphingolipid signaling pathway | 7.26E-04 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Rimexolone | hsa04072 | Phospholipase D signaling pathway | 5.67E-03 | 8 | P42338, P61586, P19174, O14986, Q14344, P63092, P23743, Q9NRA1 | PIK3CB, RHOA, PLCG1, PIP5K1B, GNA13, GNAS, DGKA, PDGFC | More | | Rimexolone | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Rimexolone | hsa04114 | Oocyte meiosis | 1.33E-02 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Rimexolone | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Rimexolone | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Rimexolone | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | | Rimexolone | hsa04141 | Protein processing in endoplasmic reticulum | 2.01E-03 | 8 | P07384, O95487, Q99941, O75460, P11142, Q9H3Z4, P07900, O95816 | CAPN1, SEC24B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, BAG2 | More | | Rimexolone | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | | Rimexolone | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Rimexolone | hsa04151 | PI3K-Akt signaling pathway | 1.16E-05 | 23 | P42338, P21860, P43657, P01106, P27348, P20827, O14944, Q9NRA1, P49767, P07900, P08238, Q15831, P62873, P63218, P50151, O15335, Q13751, P22105, P14784, P01568, Q99941, P18848, O95988 | PIK3CB, ERBB3, P2RY5, MYC, YWHAQ, EFNA1, EREG, PDGFC, VEGFC, HSP90AA1, HSP90AB1, STK11, GNB1, GNG5, GNG10, CHAD, LAMB3, TNXB, IL2RB, IFNA21, CREBL1, ATF4, TCL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P35610 | SOAT1 | Sterol O-acyltransferase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.813 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | -0.731 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.784 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P27348 | YWHAQ | 14-3-3 protein theta | 0.711 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P20827 | EFNA1 | Ephrin-A1 | -0.763 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P20827 | EFNA1 | Ephrin-A1 | -0.743 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O14944 | EREG | Proepiregulin [Cleaved into: Epiregulin | -0.778 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.711 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.718 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | 0.731 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.838 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O15335 | CHAD | Chondroadherin | -0.792 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O15335 | CHAD | Chondroadherin | -0.704 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.805 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P22105 | TNXB | Tenascin-X | 0.802 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.779 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.802 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.781 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O95988 | TCL1B | T-cell leukemia/lymphoma protein 1B | 0.719 |
| Rimexolone | hsa04152 | AMPK signaling pathway | 2.34E-02 | 2 | Q96EB6, P36956 | SIRT1, SREBF1 | More | | Rimexolone | hsa04210 | Apoptosis | 4.11E-03 | 9 | Q13315, P10415, O76075, P01375, Q9NR28, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, TNF, DIABLO, GADD45A, BCL2A1, CTSO, ITPR1 | More | | Rimexolone | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Rimexolone | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Rimexolone | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Rimexolone | hsa04217 | Necroptosis | 1.85E-03 | 7 | P01375, P01568, P48023, Q13489, Q13546, Q14765, Q99878 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT4, H2AC14 | More | | Rimexolone | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.33E-03 | 7 | P63092, P51828, Q99941, P18848, P26678, Q13557, P23634 | GNAS, ADCY7, CREBL1, ATF4, PLN, CAMK2D, ATP2B4 | More | | Rimexolone | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Rimexolone | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Rimexolone | hsa04340 | Hedgehog signaling pathway | 2.61E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Rimexolone | hsa04360 | Axon guidance | 1.80E-03 | 7 | P16333, P20827, O95631, P42338, P23528, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, CFL1, PLCG1, PTPN11 | More | | Rimexolone | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Rimexolone | hsa04371 | Apelin signaling pathway | 2.41E-03 | 7 | P62873, P63218, P50151, Q13370, Q14814, Q14344, P0DP23 | GNB1, GNG5, GNG10, PDE3B, MEF2D, GNA13, CALM1 | More | | Rimexolone | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Rimexolone | hsa04510 | Focal adhesion | 4.07E-02 | 3 | O14986, P61586, Q16363 | PIP5K1B, RHOA, LAMA4 | More | | Rimexolone | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | | Rimexolone | hsa04530 | Tight junction | 1.74E-03 | 6 | P63261, P16989, P56750, Q9Y478, Q92974, Q14247 | ACTG1, CSDA, CLDN17, PRKAB1, ARHGEF2, CTTN | More | | Rimexolone | hsa04612 | Antigen processing and presentation | 2.80E-03 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | | Rimexolone | hsa04613 | Neutrophil extracellular trap formation | 9.91E-06 | 21 | P42338, P19174, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q93077, P58876, P62807, Q93079, Q16778, O60814, P68431, P21796, P14598, Q15080, P20160, P08311, P21730 | PIK3CB, PLCG1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, H2BC9, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, VDAC1, NCF1, NCF4, AZU1, CTSG, C5AR1 | More | | Rimexolone | hsa04620 | Toll-like receptor signaling pathway | 5.54E-03 | 5 | Q13546, P01568, P42224, P25963, P42338 | RIPK1, IFNA21, STAT1, NFKBIA, PIK3CB | More | | Rimexolone | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Rimexolone | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Rimexolone | hsa04623 | Cytosolic DNA-sensing pathway | 3.38E-04 | 3 | P01568, Q13546, P25963 | IFNA21, RIPK1, NFKBIA | More | | Rimexolone | hsa04625 | C-type lectin receptor signaling pathway | 2.17E-02 | 5 | Q9ULY5, P42224, P25963, P42338, P0DP23 | CLEC4E, STAT1, NFKBIA, PIK3CB, CALM1 | More | | Rimexolone | hsa04640 | Hematopoietic cell lineage | 1.58E-02 | 6 | P13612, P20023, P11836, P09693, P01732, P13765 | ITGA4, CR2, MS4A1, CD3G, CD8A, HLA-DOB | More | | Rimexolone | hsa04650 | Natural killer cell mediated cytotoxicity | 8.06E-05 | 10 | P16298, P50591, O60880, P20963, Q02750, Q13241, P26718, O14931, P26717, P26715 | PPP3CB, TNFSF10, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, NCR3, KLRC2, KLRC1 | More | | Rimexolone | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Rimexolone | hsa04658 | Th1 and Th2 cell differentiation | 1.43E-06 | 13 | P25963, Q04759, P07766, P20963, P09693, P19174, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, CD3G, PLCG1, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Rimexolone | hsa04659 | Th17 cell differentiation | 2.00E-05 | 14 | P25963, Q04759, P19174, P42224, P14784, P13765, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, STAT1, IL2RB, HLA-DOB, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Rimexolone | hsa04660 | T cell receptor signaling pathway | 4.80E-04 | 9 | Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, Q13191 | MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB | More | | Rimexolone | hsa04662 | B cell receptor signaling pathway | 4.46E-05 | 6 | P25963, P42338, P60033, P07948, P21854, Q8N149 | NFKBIA, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Rimexolone | hsa04664 | Fc epsilon RI signaling pathway | 6.24E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Rimexolone | hsa04666 | Fc gamma R-mediated phagocytosis | 2.92E-02 | 4 | P07948, P42338, P19174, P14598 | LYN, PIK3CB, PLCG1, NCF1 | More | | Rimexolone | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Rimexolone | hsa04672 | Intestinal immune network for IgA production | 4.27E-02 | 2 | P13765, P13612 | HLA-DOB, ITGA4 | More | | Rimexolone | hsa04713 | Circadian entrainment | 5.70E-03 | 5 | P0DP23, P62873, P63218, P50151, P63092 | CALM1, GNB1, GNG5, GNG10, GNAS | More | | Rimexolone | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | | Rimexolone | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Rimexolone | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Rimexolone | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Rimexolone | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | | Rimexolone | hsa04724 | Glutamatergic synapse | 2.66E-04 | 6 | P43003, P63092, P62873, P63218, P50151, P15104 | SLC1A3, GNAS, GNB1, GNG5, GNG10, GLUL | More | | Rimexolone | hsa04725 | Cholinergic synapse | 2.92E-02 | 4 | P62873, P63218, P50151, P42338 | GNB1, GNG5, GNG10, PIK3CB | More | | Rimexolone | hsa04726 | Serotonergic synapse | 2.52E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | | Rimexolone | hsa04727 | GABAergic synapse | 8.14E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Rimexolone | hsa04744 | Phototransduction | 1.32E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Rimexolone | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.11E-03 | 7 | P01584, P51828, Q13557, P19174, P42338, P24723, P0DP23 | IL1B, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, CALM1 | More | | Rimexolone | hsa04810 | Regulation of actin cytoskeleton | 2.61E-02 | 6 | P12814, Q13009, P42338, P11215, Q14344, Q9NRA1 | ACTN1, TIAM1, PIK3CB, ITGAM, GNA13, PDGFC | More | | Rimexolone | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Rimexolone | hsa04911 | Insulin secretion | 1.60E-04 | 5 | P51828, P63092, Q99941, P18848, Q13557 | ADCY7, GNAS, CREBL1, ATF4, CAMK2D | More | | Rimexolone | hsa04914 | Progesterone-mediated oocyte maturation | 4.29E-03 | 7 | Q17RY0, P42338, Q13370, P30304, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, CDC25A, HSP90AB1, RPS6KA3, MAP2K1 | More | | Rimexolone | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Rimexolone | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Rimexolone | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Rimexolone | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Rimexolone | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Rimexolone | hsa04925 | Aldosterone synthesis and secretion | 2.47E-04 | 6 | Q99941, P18848, P51828, P63092, Q13557, P23634 | CREBL1, ATF4, ADCY7, GNAS, CAMK2D, ATP2B4 | More | | Rimexolone | hsa04926 | Relaxin signaling pathway | 8.74E-03 | 6 | P25963, P42338, P62873, P63218, P50151, P49767 | NFKBIA, PIK3CB, GNB1, GNG5, GNG10, VEGFC | More | | Rimexolone | hsa04927 | Cortisol synthesis and secretion | 2.40E-02 | 3 | Q99941, P18848, P63092 | CREBL1, ATF4, GNAS | More | | Rimexolone | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.59E-03 | 8 | Q14643, P63092, P22694, P23771, P61586, Q99941, P18848, P10415 | ITPR1, GNAS, PRKACB, GATA3, RHOA, CREBL1, ATF4, BCL2 | More | | Rimexolone | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Rimexolone | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Rimexolone | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rimexolone | hsa04934 | Cushing syndrome | 1.28E-05 | 6 | Q99941, P18848, P51828, P63092, O15169, Q13557 | CREBL1, ATF4, ADCY7, GNAS, AXIN1, CAMK2D | More | | Rimexolone | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Rimexolone | hsa04964 | Proximal tubule bicarbonate reclamation | 4.88E-02 | 1 | P49448 | GLUD2 | More | | Rimexolone | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | | Rimexolone | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | | Rimexolone | hsa04975 | Fat digestion and absorption | 9.50E-04 | 1 | O14494 | PLPP1 | More | | Rimexolone | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Rimexolone | hsa05010 | Alzheimer disease | 8.93E-04 | 13 | Q92542, O15239, P05496, P12074, O75460, P01584, P18848, O15169, P05141, P12236, P45880, P43686, P62195 | NCSTN, NDUFA1, ATP5G1, COX6A1, ERN1, IL1B, ATF4, AXIN1, SLC25A5, SLC25A6, VDAC2, PSMC4, PSMC5 | More | | Rimexolone | hsa05012 | Parkinson disease | 5.04E-04 | 15 | O15239, P05496, P05141, P12236, P21796, P60604, P63092, P18848, P43686, P62195, P19174, P0DP23, Q13557, Q71U36, Q13509 | NDUFA1, ATP5G1, SLC25A5, SLC25A6, VDAC1, UBE2G2, GNAS, ATF4, PSMC4, PSMC5, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Rimexolone | hsa05014 | Amyotrophic lateral sclerosis | 3.92E-02 | 8 | P20333, O15239, P05496, P18848, P43686, P62195, P51991, P35658 | TNFRSF1B, NDUFA1, ATP5G1, ATF4, PSMC4, PSMC5, HNRPA3, NUP214 | More | | Rimexolone | hsa05020 | Prion disease | 6.68E-04 | 13 | P01584, P46531, P11142, O15239, P05496, P12074, P18848, P05141, P12236, P45880, P43686, P62195, Q99941 | IL1B, NOTCH1, HSPA8, NDUFA1, ATP5G1, COX6A1, ATF4, SLC25A5, SLC25A6, VDAC2, PSMC4, PSMC5, CREBL1 | More | | Rimexolone | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.57E-02 | 10 | O15239, P05496, P18848, P05141, P12236, P20333, O15169, Q13557, P43686, P62195 | NDUFA1, ATP5G1, ATF4, SLC25A5, SLC25A6, TNFRSF1B, AXIN1, CAMK2D, PSMC4, PSMC5 | More | | Rimexolone | hsa05030 | Cocaine addiction | 2.40E-02 | 3 | P63092, Q99941, P18848 | GNAS, CREBL1, ATF4 | More | | Rimexolone | hsa05031 | Amphetamine addiction | 4.47E-03 | 4 | Q13557, P63092, Q99941, P18848 | CAMK2D, GNAS, CREBL1, ATF4 | More | | Rimexolone | hsa05032 | Morphine addiction | 8.92E-05 | 7 | P62873, P63218, P50151, Q13370, P48169, P63092, P43250 | GNB1, GNG5, GNG10, PDE3B, GABRA4, GNAS, GRK6 | More | | Rimexolone | hsa05034 | Alcoholism | 1.63E-06 | 12 | Q13547, P0DP23, P62873, P63218, P50151, Q93077, P58876, P62807, Q93079, Q16778, O60814, P68431 | HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, H2BC5, HIST1H2BC, H2BC9, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Rimexolone | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | | Rimexolone | hsa05132 | Salmonella infection | 1.09E-04 | 14 | P25963, P08238, P01106, P42338, Q13546, Q13489, P10415, O75369, Q9BQS8, O60282, Q71U36, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, MYC, PIK3CB, RIPK1, BIRC3, BCL2, FLNB, FYCO1, KIF5C, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Rimexolone | hsa05140 | Leishmaniasis | 4.50E-03 | 5 | P14598, O60603, P25963, P29350, Q15080 | NCF1, TLR2, NFKBIA, PTPN6, NCF4 | More | | Rimexolone | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Rimexolone | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Rimexolone | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Rimexolone | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Rimexolone | hsa05162 | Measles | 1.84E-02 | 7 | P01568, P25963, P42224, P14784, P07766, P42338, P11142 | IFNA21, NFKBIA, STAT1, IL2RB, CD3E, PIK3CB, HSPA8 | More | | Rimexolone | hsa05163 | Human cytomegalovirus infection | 5.48E-05 | 13 | P42338, P25963, P62873, P63218, P50151, P0DP23, Q14344, P61586, P01106, P63092, P30101, P61769, P01568 | PIK3CB, NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, RHOA, MYC, GNAS, PDIA3, B2M, IFNA21 | More | | Rimexolone | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.21E-06 | 15 | P01568, P42224, P25963, P42338, P62873, P62879, P63218, P50151, P19174, P16298, Q02750, P07948, P01106, P0DP23, P0CG47 | IFNA21, STAT1, NFKBIA, PIK3CB, GNB1, GNB2, GNG5, GNG10, PLCG1, PPP3CB, MAP2K1, LYN, MYC, CALM1, UBB | More | | Rimexolone | hsa05168 | Herpes simplex virus 1 infection | 4.57E-02 | 10 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, P42338, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, PIK3CB, ZNF211, ZNF189 | More | | Rimexolone | hsa05169 | Epstein-Barr virus infection | 1.32E-04 | 18 | P20023, P13765, P01106, Q13547, Q92769, O00463, P25963, P42338, P07948, P30101, Q13761, P24522, O75293, P42224, P01568, P07766, P09693, P20963 | CR2, HLA-DOB, MYC, HDAC1, HDAC2, TRAF5, NFKBIA, PIK3CB, LYN, PDIA3, RUNX3, GADD45A, GADD45B, STAT1, IFNA21, CD3E, CD3G, CD247 | More | | Rimexolone | hsa05170 | Human immunodeficiency virus 1 infection | 5.72E-05 | 15 | P42338, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, Q05397, P30101, P01568, P25963, P19174, P07766, P20333 | PIK3CB, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PDIA3, IFNA21, NFKBIA, PLCG1, CD3E, TNFRSF1B | More | | Rimexolone | hsa05200 | Pathways in cancer | 1.82E-03 | 17 | P42338, P08238, P42224, P25963, P19174, P01106, P43246, Q13547, P49767, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, MSH2, HDAC1, VEGFC, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Rimexolone | hsa05202 | Transcriptional misregulation in cancer | 2.34E-03 | 13 | Q12778, Q13315, P14780, P27930, Q16548, P11215, O15550, P05164, P08246, Q9C0K0, Q13547, P12980, P24522 | FOXO1, ATM, MMP9, IL1R2, BCL2A1, ITGAM, UTX, MPO, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | | Rimexolone | hsa05203 | Viral carcinogenesis | 1.79E-07 | 20 | Q12933, Q99941, P18848, P42229, P42338, P06746, P07948, P27348, P29083, Q13547, Q15283, P61586, P12814, P25963, P61978, P58876, P62807, Q93079, Q16778, O60814 | TRAF2, CREBL1, ATF4, STAT5A, PIK3CB, POLB, LYN, YWHAQ, GTF2E1, HDAC1, RASA2, RHOA, ACTN1, NFKBIA, HNRPK, H2BC5, HIST1H2BC, H2BC9, HIST2H2BE, H2BC12 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q12933 | TRAF2 | TNF receptor-associated factor 2 | 0.704 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.802 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.781 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P42229 | STAT5A | Signal transducer and activator of transcription 5A | 0.756 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P06746 | POLB | DNA polymerase beta | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.852 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P27348 | YWHAQ | 14-3-3 protein theta | 0.711 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P29083 | GTF2E1 | General transcription factor IIE subunit 1 | 0.786 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q15283 | RASA2 | Ras GTPase-activating protein 2 | -0.815 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q15283 | RASA2 | Ras GTPase-activating protein 2 | -0.748 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q15283 | RASA2 | Ras GTPase-activating protein 2 | -0.717 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P61586 | RHOA | Transforming protein RhoA | 0.719 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P12814 | ACTN1 | Alpha-actinin-1 | -0.729 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.878 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P58876 | H2BC5 | Histone H2B type 1-D | 0.947 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.703 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.703 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q93079 | H2BC9 | Histone H2B type 1-H | 0.756 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.793 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.72 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 |
| Rimexolone | hsa05204 | Chemical carcinogenesis | 1.77E-04 | 4 | Q16772, P09211, P78417, P11712 | GSTA3, GSTP1, GSTO1, CYP2C9 | More | | Rimexolone | hsa05206 | MicroRNAs in cancer | 2.04E-05 | 14 | P30304, P09493, P15311, P21860, P01106, P42338, P61978, P46531, Q13547, P63279, P22105, P61586, P20827, P19174 | CDC25A, TPM1, VIL2, ERBB3, MYC, PIK3CB, HNRPK, NOTCH1, HDAC1, UBE2I, TNXB, RHOA, EFNA1, PLCG1 | More | | Rimexolone | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rimexolone | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Rimexolone | hsa05212 | Pancreatic cancer | 3.52E-02 | 2 | P84022, Q13485 | SMAD3, SMAD4 | More | | Rimexolone | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Rimexolone | hsa05214 | Glioma | 1.34E-02 | 4 | P0DP23, P42338, P19174, O75293 | CALM1, PIK3CB, PLCG1, GADD45B | More | | Rimexolone | hsa05217 | Basal cell carcinoma | 2.83E-02 | 3 | Q13635, Q9UJU2, P24522 | PTCH1, LEF1, GADD45A | More | | Rimexolone | hsa05218 | Melanoma | 2.31E-02 | 3 | Q9NRA1, P42338, O75293 | PDGFC, PIK3CB, GADD45B | More | | Rimexolone | hsa05220 | Chronic myeloid leukemia | 1.14E-03 | 7 | Q13547, P01106, Q13485, P25963, P84022, P42338, O75293 | HDAC1, MYC, SMAD4, NFKBIA, SMAD3, PIK3CB, GADD45B | More | | Rimexolone | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Rimexolone | hsa05226 | Gastric cancer | 4.33E-03 | 5 | Q02750, O15169, P84022, Q13485, P10415 | MAP2K1, AXIN1, SMAD3, SMAD4, BCL2 | More | | Rimexolone | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Rimexolone | hsa05231 | Choline metabolism in cancer | 2.92E-03 | 5 | P42338, Q9NRA1, Q9Y259, P19174, P23743 | PIK3CB, PDGFC, CHKB, PLCG1, DGKA | More | | Rimexolone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.82E-03 | 10 | P25963, P42338, P19174, P07766, P20963, P09693, P42224, O60603, P10747, Q04759 | NFKBIA, PIK3CB, PLCG1, CD3E, CD247, CD3G, STAT1, TLR2, CD28, PRKCQ | More | | Rimexolone | hsa05321 | Inflammatory bowel disease | 1.44E-04 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | | Rimexolone | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Rimexolone | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Rimexolone | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Rimexolone | hsa05332 | Graft-versus-host disease | 1.61E-05 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Rimexolone | hsa05415 | Diabetic cardiomyopathy | 6.56E-03 | 7 | P05141, P12236, O15239, P05496, Q13557, P11413, P26678 | SLC25A5, SLC25A6, NDUFA1, ATP5G1, CAMK2D, G6PD, PLN | More | | |